Literature DB >> 10830917

Na+-K+ pump inhibition caused by chronic amiodarone in guinea pig myocardium.

T Maruyama1, N Ueda, Y Kaji, S Kanaya, T Fujino, Y Niho.   

Abstract

Although it is known that amiodarone inhibits myocardial Na+-K+ pump activity, the potency and the time course of this inhibition are unknown. The aim of this study was to investigate these aspects with reference to digoxin, using guinea pigs treated with either intraperitoneal amiodarone (20mg/kg per week, up to 12 weeks, n = 26) or the same amount of vehicle as a control (n = 24). ECG recording and microelectrode experiments were conducted every 2 weeks. QT interval corrected by heart rate and action potential duration were prolonged as a function of the time of exposure to amiodarone. Hyperpolarization observed immediately after the overdrive (1.0Hz) termination or K+-replenishment following K+-depletion in the presence of 0.1mM Ba2+ was compared in the amiodarone-treated and untreated groups, as an index of the Na+-K+ pump activity. The resting membrane potential recovery from overdrive-induced depolarization was slower and the amplitude of K+-induced hyperpolarization was smaller in the amiodarone-treated group than in the untreated group. These changes were evident as the chronic amiodarone treatment progressed, although the changes in these parameters were greater in the case of acute application of 50 microM digoxin. In conclusion, this study indicates that treatment with amiodarone for longer than several weeks moderately inhibits the myocardial Na+-K+ pump.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10830917     DOI: 10.1007/bf01747850

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  32 in total

1.  Rate-dependent changes in extracellular potassium in the rabbit atrium.

Authors:  D L Kunze
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

2.  Electrogenic suppression of automaticity in sheep and dog purkinje fibers.

Authors:  M Vassalle
Journal:  Circ Res       Date:  1970-09       Impact factor: 17.367

3.  Amiodarone.

Authors:  G Breithardt; L Seipel; H Kuhn
Journal:  Circulation       Date:  1980-01       Impact factor: 29.690

4.  A comparison of the electrophysiologic effects of acute and chronic amiodarone administration on canine Purkinje fibers.

Authors:  J D Gallagher; J Bianchi; L J Gessman
Journal:  J Cardiovasc Pharmacol       Date:  1989-05       Impact factor: 3.105

5.  Amiodarone blocks calcium current in single guinea pig ventricular myocytes.

Authors:  M Nishimura; C H Follmer; D H Singer
Journal:  J Pharmacol Exp Ther       Date:  1989-11       Impact factor: 4.030

6.  Effects of amiodarone on beating rate and Na-K-ATPase activity in cultured neonatal rat heart myocytes.

Authors:  M Bergman; F Cohen; H Schlesinger; G Kessler-Icekson
Journal:  Gen Pharmacol       Date:  1995-03

7.  Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

Authors:  H C Doval; D R Nul; H O Grancelli; S V Perrone; G R Bortman; R Curiel
Journal:  Lancet       Date:  1994-08-20       Impact factor: 79.321

8.  Class III antiarrhythmic action linked with positive inotropy: acute electrophysiological and inotropic effects of amiodarone in vitro.

Authors:  P M Tande; H Refsum
Journal:  Pharmacol Toxicol       Date:  1990-01

9.  Mechanisms of depressed conduction from long-term amiodarone therapy in canine myocardium.

Authors:  J H Levine; E N Moore; A H Kadish; H F Weisman; C W Balke; R F Hanich; J F Spear
Journal:  Circulation       Date:  1988-09       Impact factor: 29.690

10.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.

Authors:  S N Singh; R D Fletcher; S G Fisher; B N Singh; H D Lewis; P C Deedwania; B M Massie; C Colling; D Lazzeri
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.